Bank of New York Mellon Corp - ENZON PHARMACEUTICALS INC ownership

ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 80 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ENZON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$49,000
-34.7%
102,516
-8.1%
0.00%
Q4 2015$75,000
-26.5%
111,509
+5.5%
0.00%
Q3 2015$102,000
-17.1%
105,664
+3.1%
0.00%
Q2 2015$123,000
+21.8%
102,517
+7.4%
0.00%
Q1 2015$101,000
-2.9%
95,469
-0.4%
0.00%
Q4 2014$104,0000.0%95,812
+0.4%
0.00%
Q3 2014$104,000
-48.0%
95,468
-50.0%
0.00%
Q2 2014$200,000
-25.4%
190,938
-26.5%
0.00%
Q1 2014$268,000
-14.9%
259,736
-4.2%
0.00%
Q4 2013$315,000
-73.1%
271,154
-61.2%
0.00%
Q3 2013$1,172,000
+125.4%
698,156
+168.3%
0.00%
Q2 2013$520,000260,1690.00%
Other shareholders
ENZON PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
PRICE MICHAEL F 748,200$778,0000.10%
ALGERT GLOBAL LLC 124,891$130,0000.08%
Spark Investment Management LLC 196,500$206,0000.03%
Municipal Employees' Retirement System of Michigan 299,600$312,0000.02%
FCG ADVISORS, LLC 20,000$21,0000.02%
Icahn Capital 5,904,863$6,141,0000.02%
BRANDES INVESTMENT PARTNERS, LP 1,043,363$1,085,0000.01%
GLOBEFLEX CAPITAL L P 101,251$105,0000.01%
LMR Partners LLP 112,501$117,0000.01%
CSS LLC/IL 197,179$205,0000.01%
View complete list of ENZON PHARMACEUTICALS INC shareholders